Green Thumb Industries Inc. is trading at approximately $8.74, up 7%, following a bullish re-rating and growing optimism surrounding federal cannabis rescheduling.

  • Recent analysis upgraded the stock to a strong buy, emphasizing that a federal shift to Schedule III would eliminate the punitive 280E tax burden for compliant operators.
  • Removing the 280E restriction would allow the company to deduct standard business expenses, significantly boosting profitability and cash flow.
  • This major regulatory catalyst is driving fresh investor interest back into leading U.S. cannabis names as the sector anticipates a more favorable tax environment.